Neamati N - Search Results

1

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Ha H, Debnath B, Neamati N. Ha H, et al. Among authors: neamati n. Theranostics. 2017 Apr 7;7(6):1543-1588. doi: 10.7150/thno.15625. eCollection 2017. Theranostics. 2017. PMID: 28529637 Free PMC article. Review.

2

Small molecule inhibitors of Stat3 signaling pathway.

Deng J, Grande F, Neamati N. Deng J, et al. Among authors: neamati n. Curr Cancer Drug Targets. 2007 Feb;7(1):91-107. doi: 10.2174/156800907780006922. Curr Cancer Drug Targets. 2007. PMID: 17305481 Review.

3

HIV-1 integrase inhibitors: 2005-2006 update.

Dayam R, Gundla R, Al-Mawsawi LQ, Neamati N. Dayam R, et al. Among authors: neamati n. Med Res Rev. 2008 Jan;28(1):118-54. doi: 10.1002/med.20116. Med Res Rev. 2008. PMID: 17979144 Review.

4

Small molecules anti-HIV therapeutics targeting CXCR4.

Grande F, Garofalo A, Neamati N. Grande F, et al. Among authors: neamati n. Curr Pharm Des. 2008;14(4):385-404. doi: 10.2174/138161208783497714. Curr Pharm Des. 2008. PMID: 18289065 Review.

5

Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.

Zawahir Z, Dayam R, Deng J, Pereira C, Neamati N. Zawahir Z, et al. Among authors: neamati n. J Med Chem. 2009 Jan 8;52(1):20-32. doi: 10.1021/jm800739m. J Med Chem. 2009. PMID: 19072053

6

Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity.

Plasencia C, Grande F, Oshima T, Cao X, Yamada R, Sanchez T, Aiello F, Garofalo A, Neamati N. Plasencia C, et al. Among authors: neamati n. Cancer Biol Ther. 2009 Mar;8(5):458-65. doi: 10.4161/cbt.8.5.7741. Epub 2009 Mar 31. Cancer Biol Ther. 2009. PMID: 19221468

7

Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Cao X, Plasencia C, Kanzaki A, Yang A, Burke TR Jr, Neamati N. Cao X, et al. Among authors: neamati n. Curr Cancer Drug Targets. 2009 Mar;9(2):189-201. doi: 10.2174/156800909787580971. Curr Cancer Drug Targets. 2009. PMID: 19275759 Free PMC article.

8

Combination effects of SC144 and cytotoxic anticancer agents.

Oshima T, Cao X, Grande F, Yamada R, Garofalo A, Louie S, Neamati N. Oshima T, et al. Among authors: neamati n. Anticancer Drugs. 2009 Jun;20(5):312-20. doi: 10.1097/CAD.0b013e328323a7ca. Anticancer Drugs. 2009. PMID: 19322070

9

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.

Pathania D, Millard M, Neamati N. Pathania D, et al. Among authors: neamati n. Adv Drug Deliv Rev. 2009 Nov 30;61(14):1250-75. doi: 10.1016/j.addr.2009.05.010. Epub 2009 Aug 27. Adv Drug Deliv Rev. 2009. PMID: 19716393 Review.

10

HIV-1 integrase inhibitors: 2007-2008 update.

Ramkumar K, Serrao E, Odde S, Neamati N. Ramkumar K, et al. Among authors: neamati n. Med Res Rev. 2010 Nov;30(6):890-954. doi: 10.1002/med.20194. Med Res Rev. 2010. PMID: 20135632 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results